Where Are the Real-time Tools for Drug Price Transparency?

Drug affordability causes some 20% of patients not to adhere to recommended pharmaceutical approaches

Where Are the Real-time Tools for Drug Price Transparency?
  • Among survey respondents, those reporting cost-related nonadherence were between ages 65 and 69, less likely to be college educated, and more likely to report lower incomes.
  • Cost-coping strategies that were reported included using copay cards or coupons, asking doctors for lower-cost alternatives, shopping around at different pharmacies, requesting samples, delaying medical care, and foregoing basic necessities.
  • Nearly all patients want accurate real-time tools and prices, but a number of barriers to implementation stand in the way: incomplete data; interoperability challenges between drug plan, insurer data, and electronic health records; and inadequate investment from health systems.


Dusetzina SB, Besaw RJ, Whitmore C, et al. Cost-Related Medication Nonadherence and Desire for Medication Cost Information Among Adults Aged 65 Years and Older in the US in 2022. JAMA Network Open. 2023;6:e2314211.